StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionAug 11, 2026, 02:21 PM

Genmab Increases Capital by 24,592 Shares from Warrant Exercise

AI Summary

Genmab A/S announced a capital increase of 24,592 shares as a result of employee warrant exercises. This action, conducted without preemption rights for existing shareholders, generated approximately DKK 37.9 million in proceeds for the company. The increase represents about 0.04% of the company's share capital, bringing the total nominal value to DKK 62,377,844.

Key Highlights

  • Capital increased by 24,592 new shares due to employee warrant exercise.
  • Proceeds to the company totaled approximately DKK 37.9 million.
  • The increase corresponds to approximately 0.04% of the company's share capital.
  • New shares subscribed at DKK 1,334.50, DKK 1,362.50, and DKK 1,615.00.
  • Total nominal share capital after increase is DKK 62,377,844.